Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      USFDA, Indian Government Join hands to clamp down on Illicit Medical Products

      USFDA, Indian Government Join hands to clamp down on Illicit Medical Products

      Medical Dialogues Bureau19 Feb 2020 12:54 PM IST
      US: The U.S. Food and Drug Administration today announced that its first bilateral enforcement operation with the Government of India stopped...
      Minister inaugurates Syngene new RnD centre in Hyderabad

      Minister inaugurates Syngene new RnD centre in Hyderabad

      Medical Dialogues Bureau18 Feb 2020 4:19 PM IST
      This is Syngene International Ltd.'s first operational research centre outside Bengaluru. When fully commissioned by the end of this year at an...
      Govt approved Rs 1750 crore proposal for strengthening drug regulatory system

      Govt approved Rs 1750 crore proposal for strengthening drug regulatory system

      Medical Dialogues Bureau18 Feb 2020 2:56 PM IST
      Out of this, Rs 900 crore is for strengthening the central drug regulator structure and Rs 850 crore is for strengthening the drug regulatory system...
      Marketing right for SGLT2 inhibitor Apleway to be transferred from Sanofi to Kowa

      Marketing right for SGLT2 inhibitor Apleway to be transferred from Sanofi to Kowa

      Medical Dialogues Bureau18 Feb 2020 12:53 PM IST
      Chugai and Sanofi agreed to terminate their license agreement. Kowa and Sanofi agreed that the marketing right for Apleway will be transferred from...
      AstraZeneca 2020 revenue rises, sales growth to take coronavirus hit

      AstraZeneca 2020 revenue rises, sales growth to take coronavirus hit

      Medical Dialogues Bureau18 Feb 2020 10:30 AM IST
      AstraZeneca said the guidance assumed an unfavourable impact from China lasting up to a few months as a result of the outbreak, which has killed over...
      Merck Keytruda, Chemotherapy combo meets endpoint for first-line treatment of Breast Cancer

      Merck Keytruda, Chemotherapy combo meets endpoint for first-line treatment of Breast Cancer

      Medical Dialogues Bureau18 Feb 2020 10:15 AM IST
      New Delhi: Merck known as MSD outside the United States and Canada, recently announced that the pivotal Phase 3 KEYNOTE-355 trial investigating...
      USFDA completes inspection of Lupins Aurangabad facility

      USFDA completes inspection of Lupin's Aurangabad facility

      Medical Dialogues Bureau17 Feb 2020 4:18 PM IST
      Mumbai: Pharma major Lupin Limited (Lupin) announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection carried...
      Antios Therapeutics Initiates First-in-Human Phase I Study of ATI-2173

      Antios Therapeutics Initiates First-in-Human Phase I Study of ATI-2173

      Medical Dialogues Bureau17 Feb 2020 3:51 PM IST
      Atlanta: Antios Therapeutics, Inc a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure...
      USFDA seeks voluntary action at Dr Reddys Duvvada facility

      USFDA seeks voluntary action at Dr Reddy's Duvvada facility

      Medical Dialogues Bureau17 Feb 2020 3:10 PM IST
      New Delhi: The US health regulator has asked drug major Dr Reddy's Laboratories to initiate voluntary action at its Duvvada facility in Andhra...
      Unichem, Macleods Pharma recall drugs from US market

      Unichem, Macleods Pharma recall drugs from US market

      Medical Dialogues Bureau17 Feb 2020 3:09 PM IST
      The reason for the voluntary ongoing nationwide is "failed impurities/degredation specifications.
      Zydus Cadila announces research Program to develop Coronavirus Vaccine

      Zydus Cadila announces research Program to develop Coronavirus Vaccine

      Medical Dialogues Bureau17 Feb 2020 2:56 PM IST
      Zydus has two state-of-the-art R&D Centres, one located in Catania, Italy and the other in Ahmedabad, in the western part of India
      Govt taking steps to reduce dependence on import of antibiotic raw materials: Minister

      Govt taking steps to reduce dependence on import of antibiotic raw materials: Minister

      Medical Dialogues Bureau16 Feb 2020 11:00 AM IST
      As per the information received from the port offices of the Central Drugs Standard Control Organisation (CDSCO), it stood at 12,006.11 metric tonnes...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok